vs

Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $37.2M, roughly 1.3× Organogenesis Holdings Inc.). On growth, ACACIA RESEARCH CORP posted the faster year-over-year revenue change (2.6% vs -57.1%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs -46.5%).

Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

ACTG vs ORGO — Head-to-Head

Bigger by revenue
ACTG
ACTG
1.3× larger
ACTG
$50.1M
$37.2M
ORGO
Growing faster (revenue YoY)
ACTG
ACTG
+59.7% gap
ACTG
2.6%
-57.1%
ORGO
Faster 2-yr revenue CAGR
ACTG
ACTG
Annualised
ACTG
43.6%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ACTG
ACTG
ORGO
ORGO
Revenue
$50.1M
$37.2M
Net Profit
$3.4M
Gross Margin
12.8%
30.8%
Operating Margin
-26.1%
-185.1%
Net Margin
6.8%
Revenue YoY
2.6%
-57.1%
Net Profit YoY
125.5%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACTG
ACTG
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$50.1M
$225.6M
Q3 25
$59.4M
$150.9M
Q2 25
$51.2M
$101.0M
Q1 25
$124.4M
$86.7M
Q4 24
$48.8M
$126.7M
Q3 24
$23.3M
$115.2M
Q2 24
$25.8M
$130.2M
Net Profit
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
$3.4M
$43.7M
Q3 25
$-2.7M
$21.6M
Q2 25
$-3.3M
$-9.4M
Q1 25
$24.3M
$-18.8M
Q4 24
$-13.4M
$7.7M
Q3 24
$-14.0M
$12.3M
Q2 24
$-8.4M
$-17.0M
Gross Margin
ACTG
ACTG
ORGO
ORGO
Q1 26
30.8%
Q4 25
12.8%
Q3 25
21.2%
Q2 25
12.8%
Q1 25
47.4%
72.6%
Q4 24
17.6%
75.5%
Q3 24
10.1%
76.7%
Q2 24
26.2%
77.6%
Operating Margin
ACTG
ACTG
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-26.1%
28.1%
Q3 25
-10.8%
13.7%
Q2 25
-24.2%
-12.5%
Q1 25
30.8%
-30.9%
Q4 24
-32.4%
8.1%
Q3 24
-44.1%
5.4%
Q2 24
-18.4%
-10.7%
Net Margin
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
6.8%
19.4%
Q3 25
-4.6%
14.3%
Q2 25
-6.4%
-9.3%
Q1 25
19.5%
-21.7%
Q4 24
-27.5%
6.1%
Q3 24
-60.0%
10.7%
Q2 24
-32.7%
-13.1%
EPS (diluted)
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
$0.03
$0.31
Q3 25
$-0.03
$0.11
Q2 25
$-0.03
$-0.10
Q1 25
$0.25
$-0.17
Q4 24
$-0.14
$0.05
Q3 24
$-0.14
$0.09
Q2 24
$-0.08
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACTG
ACTG
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$306.7M
$91.4M
Total DebtLower is stronger
$91.9M
Stockholders' EquityBook value
$543.5M
Total Assets
$771.0M
$520.0M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACTG
ACTG
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$306.7M
$93.7M
Q3 25
$301.8M
$63.7M
Q2 25
$316.7M
$73.1M
Q1 25
$272.0M
$110.0M
Q4 24
$273.9M
$135.6M
Q3 24
$410.9M
$94.3M
Q2 24
$441.9M
$89.9M
Total Debt
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
$91.9M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
$543.5M
$300.1M
Q3 25
$537.6M
$255.1M
Q2 25
$538.6M
$233.2M
Q1 25
$540.2M
$242.9M
Q4 24
$514.8M
$262.9M
Q3 24
$540.2M
$278.5M
Q2 24
$560.7M
$263.5M
Total Assets
ACTG
ACTG
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$771.0M
$598.7M
Q3 25
$768.9M
$509.8M
Q2 25
$775.5M
$461.1M
Q1 25
$801.6M
$467.4M
Q4 24
$756.4M
$497.9M
Q3 24
$707.6M
$446.3M
Q2 24
$753.6M
$443.2M
Debt / Equity
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACTG
ACTG
ORGO
ORGO
Operating Cash FlowLast quarter
$75.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
22.01×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
$75.2M
$39.4M
Q3 25
$9.5M
$3.1M
Q2 25
$50.1M
$-32.9M
Q1 25
$2.4M
$-19.9M
Q4 24
$50.1M
$10.9M
Q3 24
$-593.0K
$8.7M
Q2 24
$16.1M
$4.7M
Free Cash Flow
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$335.0K
$-23.6M
Q4 24
$-98.5M
$7.6M
Q3 24
$-2.8M
$6.1M
Q2 24
$-126.7M
$2.9M
FCF Margin
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
0.3%
-27.2%
Q4 24
-201.8%
6.0%
Q3 24
-12.1%
5.3%
Q2 24
-490.5%
2.2%
Capex Intensity
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
1.7%
4.2%
Q4 24
304.4%
2.7%
Q3 24
9.6%
2.2%
Q2 24
553.0%
1.4%
Cash Conversion
ACTG
ACTG
ORGO
ORGO
Q1 26
Q4 25
22.01×
0.90×
Q3 25
0.14×
Q2 25
Q1 25
0.10×
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACTG
ACTG

Energy Operations$16.0M32%
Transportation Safety$10.4M21%
Office Storage And Display Solutions$8.4M17%
Printers Consumables And Parts$6.5M13%
Natural Gas Reserves$5.1M10%
Natural Gas Liquids Reserves$3.3M7%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons